The HARMONY Alliance will be participating in the 18th annual Eyeforpharma meeting on March 31–April 2, 2020, in Barcelona. The meeting brings together pharma industry leaders from across the globe to discuss topics such as the evolving landscapes of real-world evidence, regulatory decision making and the pharma industry.
Yann Guillevic, Celgene (HARMONY co-lead), will be presenting on real-world evidence and big data. Details of the presentation:
Watch Yann Guillevic share his views on HARMONY and Big Data:
Stay tuned for more details!
The annual Eyeforpharma meeting brings together more than 2000 pharma leaders and healthcare innovators to share knowledge on regulatory decision making and to discuss the future of the pharmaceutical industry. Click here to visit the official eyeforpharma meeting website.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
